Latest news

Filter by
Date
MEDIA RELEASE: Nov 09, 2017 06:02 AM

Long-term survivors of pancreatic cancer have ‘built-in immu...

In long-term survivors of pancreatic cancer, the immune system sees the cancer as an infectious disease – and so is empowered to attack and destroy tumour cells, according to findings published today in Nature. The Austr...

MEDIA RELEASE: Nov 01, 2017 05:54 AM

Breakthrough breast cancer drug targets a major type of panc...

A newly approved breast cancer drug could be highly effective against some forms of pancreatic cancer, including metastatic cancer, Australian researchers have found.

Oct 31, 2017 04:30 PM

‘Connie’s Heart’ raises $110,000 for cancer research

The large-scale artwork ‘Connie’s Heart’, by Marie Ramos, has this week been unveiled at Garvan by Samuel Johnson OAM. Inspired by Connie Johnson and Love Your Sister, the artwork was a year in the making and has raised ...

MEDIA RELEASE: Oct 24, 2017 06:30 AM

DreamLab app speeding up Garvan’s cancer research

The DreamLab app, a distributed smartphone supercomputer, is now available on iOS and Android. Garvan and The Vodafone Foundation are now calling one million Australians to download the app and contribute to Garvan’s can...

Oct 18, 2017 09:47 AM

Leading genomic data projects to drive a new ‘world of knowl...

Garvan researchers are key contributors to three genomic data initiatives selected as key Driver Projects by the Global Alliance for Genomics and Health (GA4GH) in a 5-year vision to fully realise the promise of genomic ...

MEDIA RELEASE: Oct 11, 2017 08:33 AM

Blockchain tech: Garvan partners with E-Nome

Garvan has signed a memorandum of understanding with E-Nome Pty Ltd, an Australian technology startup driving the application of blockchain technology to the secure storage of health records. Together, Garvan and E-Nome ...

Oct 10, 2017 04:49 PM

The importance of returning research results to study partic...

Researchers from Garvan and the Australian Pancreatic Cancer Genome Initiative have explored the feasibility and value of returning the results of genomic research studies to study participants.

MEDIA RELEASE: Oct 06, 2017 05:00 AM

Biosensor mouse lights up health and disease

Garvan researchers have developed a biosensor mouse that gives a real-time readout of the rapidly changing ‘skeleton’ within cells. The researchers have watched cells respond dynamically to their surrounding environment ...

Sep 18, 2017 06:00 PM

Now open: Zero Childhood Cancer program to deliver personali...

The Garvan Institute, with the Lions Clubs International Foundation and the Australian Lions Childhood Cancer Research Foundation, is proud to be a partner in the Zero Childhood Cancer national child cancer personalised ...

Sep 13, 2017 12:00 PM

Dubbo Osteoporosis Epidemiology Study

Take 5000 people, scrutinise for three decades and what do you get? A wholly new understanding of osteoporosis for starters, and the insights keep on coming.

Sep 11, 2017 08:51 AM

Vale Connie Johnson OAM

Vale Constance (Connie) Johnson OAM 1977 – 2017.

MEDIA RELEASE: Sep 07, 2017 10:48 PM

‘Partner in crime’ mutations work together to kickstart lymp...

Australian researchers have uncovered ‘extraordinary cooperation’ between two DNA mutations that are often found together in lymphomas and leukaemias. The findings help us understand how immune cells can ‘go rogue’, beha...

Aug 31, 2017 01:20 PM

Professor Mark Febbraio: exercise is medicine

Garvan congratulates Professor Mark Febbraio, who has won the 2017 Australian Diabetes Society (ADS) Kellion Award. The award recognises an Australian researcher who has made an outstanding contribution to diabetes resea...

MEDIA RELEASE: Aug 23, 2017 06:00 AM

Ground-breaking trial brings personalised treatments to thos...

Garvan's Genomic Cancer Medicine Program, launched today by The Hon. Brad Hazzard, uses genomic medicine to match therapies, prevention and screening methods with rare cancer patients based on their genetic information.

Aug 16, 2017 07:09 AM

Rare Cancers Australia sets new agenda for change

Garvan is proud to support Rare Solutions: A Time to Act, a new report released by Rare Cancers Australia that sets out a roadmap for change in the treatment and care of patients with rare cancer in Australia.

MEDIA RELEASE: Aug 04, 2017 01:00 AM

Top-to-toe MRI screen picks up early-stage cancers while sti...

A major study shows that whole-body MRI screening can identify previously undetected primary tumours throughout the body in people with high genetic risk of cancer.

Jul 14, 2017 11:30 AM

Immunotherapy – changing the way we think about cancer treat...

Garvan scientists are looking beyond their specialty areas and taking an inter-disciplinary approach that is changing the way we think about the treatment of cancer.

Jul 07, 2017 11:10 AM

Interleukin-2: releasing an immune system brake to attack tu...

Researchers from Garvan’s Immunology Division have been exploring ways to make interleukin-2 immunotherapy less toxic and more effective against cancer. In doing so, the team has uncovered surprising new information abou...

MEDIA RELEASE: Jun 30, 2017 05:00 AM

Promising new therapeutic approach rebuilds and strengthens ...

Garvan researchers demonstrate that a new therapeutic approach increases bone strength and resistance to fractures in multiple myeloma bone disease

Jun 16, 2017 09:00 PM

When one becomes two: an intricate new roadmap for cell divi...

Dr Andrew Burgess and Professor Sean O’Donoghue have brought Garvan and CSIRO researchers and biodata visualisation specialists together to produce an interactive graphical representation of how a cell divides.

MEDIA RELEASE: May 16, 2017 10:42 PM

Tumour-trained T cells go on patrol

‘Tumour-trained’ immune cells – which have the potential to kill cancer cells – have been seen moving from one tumour to another for the first time. The new findings, which were uncovered by scientists at Sydney’s Garvan...